Editorial
doi: 10.1161/CIR.0b013e3181d83b4f.
Epub 2010 Mar 1.
Seeking alternatives to Hard End Points: is imaging the best APPROACH?
- PMID: 20194886
- DOI: 10.1161/CIR.0b013e3181d83b4f
Item in Clipboard
Editorial
Seeking alternatives to Hard End Points: is imaging the best APPROACH?
Circulation.
.
No abstract available
Comment on
-
Effect of rosiglitazone on progression of coronary atherosclerosis in patients with type 2 diabetes mellitus and coronary artery disease: the assessment on the prevention of progression by rosiglitazone on atherosclerosis in diabetes patients with cardiovascular history trial.Circulation. 2010 Mar 16;121(10):1176-87. doi: 10.1161/CIRCULATIONAHA.109.881003. Epub 2010 Mar 1. Circulation. 2010. PMID: 20194881 Clinical Trial.
Similar articles
-
PERISCOPE and the effect of pioglitazone on the progression of coronary artery disease in patients with diabetes.Diab Vasc Dis Res. 2008 Nov;5(4):345-6. doi: 10.3132/dvdr.2008.048. Diab Vasc Dis Res. 2008. PMID: 18958845 No abstract available.
-
PERISCOPE: pioglitazone offers the right cluster of effects to confer benefit in type 2 diabetes.Cardiovasc J Afr. 2008 May-Jun;19(3):159-62. Cardiovasc J Afr. 2008. PMID: 18568180 No abstract available.
-
Pioglitazone vs glimepiride in the PERISCOPE trial.JAMA. 2008 Aug 20;300(7):787-8; author reply 788. doi: 10.1001/jama.300.7.787-b. JAMA. 2008. PMID: 18714054 No abstract available.
-
[The effect of glitazones on the progression of type 2 diabetes and on cardiovascular endpoints].Dtsch Med Wochenschr. 2005 Aug 5;130(31-32):1825-30. doi: 10.1055/s-2005-871905. Dtsch Med Wochenschr. 2005. PMID: 16052448 Review. German. No abstract available.
-
Dyslipidaemia in type 2 diabetes: effects of the thiazolidinediones pioglitazone and rosiglitazone.Diabet Med. 2005 Jul;22 Suppl 3:6-10. doi: 10.1111/j.1466-5468.2005.01711c.x. Diabet Med. 2005. PMID: 15960775 Review. No abstract available.
Cited by
-
Assessment of atherosclerotic plaque burden with an elastin-specific magnetic resonance contrast agent.Nat Med. 2011 Mar;17(3):383-8. doi: 10.1038/nm.2310. Epub 2011 Feb 20. Nat Med. 2011. PMID: 21336283
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
